The Role of Antiangiogenic Drugs in the Treatment of Diabetic Macular Edema

Naimov Dilshod Qayim o’g’li

Article Sidebar

Issue
Vol. 1 No. 4 (2023): Journal of Science in Medicine and Life
Keywords:
    diabetic macular edema, antiangiogenic therapy, ranibizumab
View Article

Abstract

The article presents the characteristics of the first antiangiogenic drug registered for the treatment of diabetic macular edema, ranibizumab, as well as the new long-acting drug brolucizumab.

Full text article

Generated from XML file

Authors

Naimov Dilshod Qayim o’g’li
Bukhara State Medical Institute, Assistant of the Department of Internal Medicine, Uzbekistan, Bukhara
o’g’li, N. D. Q. (2023). The Role of Antiangiogenic Drugs in the Treatment of Diabetic Macular Edema. Journal of Science in Medicine and Life, 1(4), 97–101. Retrieved from https://journals.proindex.uz/index.php/JSML/article/view/422
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX
Copyright and license info is not available

Article Details